You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聖濟堂(600227.SH):原料藥(鹽酸多奈哌齊)通過GMP現場檢查
格隆匯 04-08 15:45

格隆匯4月8日丨聖濟堂(600227.SH)公佈,根據貴州省藥品監督管理局發佈的《貴州省藥品GMP現場檢查結果公告》,公司全資子公司貴州聖濟堂製藥有限公司(以下簡稱“聖濟堂製藥”)原料藥(鹽酸多奈哌齊)經現場檢查和綜合評定,符合藥品GMP要求。

鹽酸多奈哌齊適用於輕度或中度阿爾茨海默型痴呆症狀的治療,是聖濟堂製藥產品鹽酸多奈哌齊片的主要原料。據米內網數據顯示,2017年在中國城市公立醫院、縣級公立醫院、城市社區中心及鄉鎮衞生院(簡稱中國公立醫療機構)終端,鹽酸多奈哌齊片劑的銷售額達到6.80億元。2018年公司鹽酸多奈哌齊片銷售收入約875萬元,佔銷售收入1.28%,2019年銷售收入約703萬元,佔銷售收入2.21%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account